Do you want to read an article? Please log in or register.
Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry
Atrial Fibrillation
Related content
Atrial FibrillationHeart Failure
Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry
Heart Rhythm
Yousuf O, Akar J, Tan Z, Alkalbani M, Tasneem H, Steinberg BA, Hsu JC, Atwater B, Yang E, Spertus J, Calkins H, Freeman JV
doi: 10.1016/j.hrthm.2025.06.048
Atrial Fibrillation
Cardiovascular-kidney-metabolic syndrome and atrial fibrillation: Insights from 2 real-world prospective registries across Europe and East Asia
Heart Rhythm
Askarinejad A, Bucci T, Tartaglia E, Rossi M, Rigutini AG, Tse HF, Boriani G, Chao TF, Lip GYH
doi: 10.1016/j.hrthm.2026.02.038
Atrial Fibrillation
Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial
Heart Rhythm
Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators
doi: 10.1016/j.hrthm.2025.07.002
Atrial Fibrillation
Inverse association between remnant cholesterol and risks of atrial fibrillation among patients with type 2 diabetes
Front Endocrinol (Lausanne)
Jiang Z, Zhao K, Sun M, Sun J, Pan S
doi: 10.3389/fendo.2025.1461613
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2
Myocardial Infarction
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries
Circ Cardiovasc Qual Outcomes
Mentias A, Keshvani N, Desai MY, Kapadia S, Ziada KM, McCarthy CP, Hall HM, Park K, Kumbhani DJ, Lincoff AM, Januzzi JL Jr, Pandey A
doi: 10.1161/CIRCOUTCOMES.125.012136
Cardiovascular Risk and Diseases
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III
Cardiovasc Diabetol
Romiti GF, Mei DA, Corica B, Proietti M, Boriani G, Olshansky B, Chao TF, Huisman MV, Lip GYH, GLORIA-AF Investigators
doi: 10.1186/s12933-025-02950-y
Atrial Fibrillation
Age-Related Differences in the Clinical Profile and Management of Atrial Fibrillation: Results from the Multicentre REGUEIFA Registry
J Clin Med
López-Pena AM, Elices-Teja J, Durán-Bobín O, González-Melchor L, Vázquez-Caamaño M, Fernández-Obanza E, González-Babarro E, Cabanas-Grandío P, Piñeiro-Portela M, Prada-Delgado O, Gutiérrez-Feijoo M, Freire E, Díaz-Castro O, Muñiz J, García-Seara J, González-Juanatey C
doi: 10.3390/jcm15051955
Atrial Fibrillation
Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III
J Am Heart Assoc
Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Olshansky B, Huisman MV, Lip GYH, GLORIA‐AF Investigators
doi: 10.1161/JAHA.125.044293